Atlas Trials

Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma

Clinical trial NCT00148018 · TERMINATED

Trial details

NCT number
NCT00148018
Sponsor
University of Cologne
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hodgkin Disease
Start date
2005-03-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.